We are proud to announce the latest impact factors (IFs) for the British Society for Immunology’s official journals: Clinical & Experimental Immunology has achieved an IF of 3.532 and Immunology has reached it's highest ever IF of 5.016 .
We’d like to take this opportunity to celebrate our journals for building upon their position as highly respected publications within the field of immunology.
We’d like to thank our editorial teams, led by Editors-in-Chief Leonie Taams and Simon Milling, for their ongoing commitment to the journals, and everyone who has contributed to the continued success of our journals, including authors, readers, reviewers and editors.
Whilst we are aware that the impact factor has certain limitations, we take this as one measure of the high quality work submitted by our authors, contributing highly cited reviews and research, which we have highlighted here.
We are continuing to achieve our goal of publishing content which is timely and relevant to our research community, as demonstrated by the high Altmetric scores and downloads of our articles.
We would also like to take this opportunity to highlight other successes from our journals:
Clinical & Experimental Immunology
- Mean time to first decision: 16 days
- Mean time to final decision: 31 days
- Average monthly usage: 52,853 full text downloads
- 5 year impact factor: 3.472
- Immediacy index: 1.397
- Mean time to first decision: 22 days
- Mean time to final decision: 39 days
- Average monthly usage: 49,877 full text downloads
- 5 year impact factor: 4.324
- Immediacy index: 1.234
Here you can find information about Immunology and Clinical & Experimental Immunology. Profits derived from the sale of the journals are invested back into the BSI to benefit our members in the form of grants, our new webinar series, our Regional and Affinity Group activities, our popular annual Congress and other key initiatives. We encourage you to support the BSI by submitting your work.